Valero, A.; Rodríguez-Gascón, A.; Isla, A.; Barrasa, H.; del Barrio-Tofiño, E.; Oliver, A.; Canut, A.; Solinís, M.Á.
Pseudomonas aeruginosa Susceptibility in Spain: Antimicrobial Activity and Resistance Suppression Evaluation by PK/PD Analysis. Pharmaceutics 2021, 13, 1899.
https://doi.org/10.3390/pharmaceutics13111899
AMA Style
Valero A, Rodríguez-Gascón A, Isla A, Barrasa H, del Barrio-Tofiño E, Oliver A, Canut A, Solinís MÁ.
Pseudomonas aeruginosa Susceptibility in Spain: Antimicrobial Activity and Resistance Suppression Evaluation by PK/PD Analysis. Pharmaceutics. 2021; 13(11):1899.
https://doi.org/10.3390/pharmaceutics13111899
Chicago/Turabian Style
Valero, Ana, Alicia Rodríguez-Gascón, Arantxa Isla, Helena Barrasa, Ester del Barrio-Tofiño, Antonio Oliver, Andrés Canut, and María Ángeles Solinís.
2021. "Pseudomonas aeruginosa Susceptibility in Spain: Antimicrobial Activity and Resistance Suppression Evaluation by PK/PD Analysis" Pharmaceutics 13, no. 11: 1899.
https://doi.org/10.3390/pharmaceutics13111899
APA Style
Valero, A., Rodríguez-Gascón, A., Isla, A., Barrasa, H., del Barrio-Tofiño, E., Oliver, A., Canut, A., & Solinís, M. Á.
(2021). Pseudomonas aeruginosa Susceptibility in Spain: Antimicrobial Activity and Resistance Suppression Evaluation by PK/PD Analysis. Pharmaceutics, 13(11), 1899.
https://doi.org/10.3390/pharmaceutics13111899